CVD Trials Type 2 diabetes mellitus (T2DM), obesity, dyslipidemia, and hypertension are major players in the development of cardiovascular disease (CVD)
Conclusions In this large real-world cohort of patients with type 2 diabetes and pre-existing aortic aneurysm, GLP-1RA therapy was associated with significantly lower risks of aortic rupture/dissection, hypertensive crisis, and all-cause mortality compared with DPP-4i therapy
Plus, it may also cause primary pulmonary hypertension or valvular heart disease, which is why people with existing or previous cardiovascular conditions should avoid it
This lack of motility, the muscle movements within your GI tract that move food forward through the digestive process, causes nausea, vomiting, and premature fullness
If youre on this path, Id like to hear from you